SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-17-048989
Filing Date
2017-09-21
Accepted
2017-09-21 10:17:35
Documents
4
Group Members
BRIAN STRAUSSDR. WILLIAM KAYRICHARD D. HORNIDGE, JR.RICHARD KWAKROBERT DAVISRON HIRSCHIRONALD K. TOLBOESTEVE ROEHRICHTED KUSTIN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A v475565_sc13da.htm SC 13D/A 202527
2 EXHIBIT 3 v475565_ex99-3.htm EX-3 5623
3 EXHIBIT 4 v475565_ex99-4.htm EX-4 21644
4 EXHIBIT 5 v475565_ex99-5.htm EX-5 13929
  Complete submission text file 0001144204-17-048989.txt   245427
Mailing Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824
Business Address 1375 KINGS HIGHWAY EAST FAIRFIELD CT 06824 (203) 368-6044
CALMARE THERAPEUTICS Inc (Subject) CIK: 0000102198 (see all company filings)

IRS No.: 362664428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-30128 | Film No.: 171095218
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 160 RIO KOBLES SAN JOSE CA 95130
Business Address
YARBRO STAN (Filed by) CIK: 0001269921 (see all company filings)

Type: SC 13D/A